Main Street Financial Solutions’s Matinas BioPharma MTNB Stock Holding History

Main Street Financial Solutions’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,017	Closed	-$63.5K	–	563
2024 Q2	$63.5K	Hold	8,017	–	–	0.01%	525
2024 Q1	$109K	Hold	8,017	–	–	0.01%	499
2023 Q4	$86.7K	Hold	8,017	–	–	0.01%	442
2023 Q3	$52.1K	Hold	8,017	–	–	0.01%	444
2023 Q2	$144K	Hold	8,017	–	–	0.02%	432
2023 Q1	$188K	Hold	8,017	–	–	0.03%	433
2022 Q4	$200K	Hold	8,017	–	–	0.03%	418
2022 Q3	$255K	Hold	8,017	–	–	0.04%	361
2022 Q2	$317K	Hold	8,017	–	–	0.04%	333
2022 Q1	$322K	Hold	8,017	–	–	0.05%	348
2021 Q4	$405K	Hold	8,017	–	–	0.06%	315
2021 Q3	$521K	Hold	8,017	–	–	0.08%	242
2021 Q2	$311K	Hold	8,017	–	–	0.05%	349
2021 Q1	$421K	Hold	8,017	–	–	0.08%	246
2020 Q4	$545K	Buy	+8,017	New	+$371K	0.11%	188

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

Main Street Financial Solutions's MTNB Position: Q3 2024 in Review

Main Street Financial Solutions sold out of Matinas BioPharma (MTNB) in Q3 2024, closing a stake of 8,017 shares — an estimated $63.5K sold.

Main Street Financial Solutions first reported a position in MTNB in Q4 2020 and held it in 15 quarters. The position peaked at $545K in Q4 2020. 18 funds tracked by Wall St. Rank hold MTNB as of Q3 2024.

Main Street Financial Solutions reported no remaining Matinas BioPharma position as of Q3 2024 after selling out during the quarter.
Main Street Financial Solutions sold 8,017 Matinas BioPharma shares in Q3 2024, an estimated $63.5K.
Main Street Financial Solutions first reported a position in Matinas BioPharma in Q4 2020 and held it in 15 quarters.
Main Street Financial Solutions's Matinas BioPharma position peaked at $545K in Q4 2020.
18 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2024.

Based on Main Street Financial Solutions's 13F filing for Q3 2024, filed 5 Nov 2024.